MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • 2016 International Congress

    Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder

    F. Escudier, R.B. Postuma, P.A. Bourgouin, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

    Objective: To explore the relationship between parkinsonism signs and anxiety symptoms in patients with idiopathic REM sleep behavior disorder (iRBD). Background: A recent study reported…
  • 2016 International Congress

    Cognitive impairment in Parkinson’s disease

    B. Kurbanov (Tashkent, Uzbekistan)

    Objective: To study features of cognitive symptoms in PD, depending on the severity of the disease. Background: Parkinson's disease (PD) is shown a wide range…
  • 2016 International Congress

    The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

    L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)

    Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • 2016 International Congress

    The effects of fluvoxamine maleate in a post-natal stress rat model of neurodegeneration

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: In this study, we investigated whether treatment of anxiety-like symptoms with Fluvoxamine maleate alleviates the neurotoxic effects of 6-OHDA in a Parkinsonian rat model.…
  • 2016 International Congress

    The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients

    N. Ongun, C. Erdogan, E. Degirmenci, L.S. Bir (Denizli, Turkey)

    Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    Anxiety and freezing of gait: A new perspective for early intervention

    K.A. Ehgoetz Martens, J.M. Hall, M. Gilat, M.J. Georgiades, C.C. Walton, S.J.G. Lewis (Camperdown, Australia)

    Objective: The current study evaluated (i) whether PD+FOG have greater anxiety compared to PD-NF, and (ii) whether anxiety in PD is related to executive dysfunction,…
  • 2016 International Congress

    Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)

    K. Dashtipour, J.J. Chen, L. Massihi, S. Tashiro, K. Frei (Loma Linda, CA, USA)

    Objective: To conduct a systematic review to evaluate the efficacy, safety, and dosing range of quetiapine for the treatment for hallucinosis / psychosis in patients…
  • 2016 International Congress

    Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain

    G. Pavlic, I. Moldovanu, N. Diaconu, L. Rotaru (Chisinau, Republic of Moldova)

    Objective: The study objective was to assess the neuropsychiatric profile in Moldavian Parkinson's disease patients with chronic pain. Background: Psychological factors can influence both the…
  • 2016 International Congress

    Effect of STN-DBS on impulse control disorder and affective behavioral complications of Parkinson’s disease: A 1-year longitudinal study

    S.M. Omarova, N.V. Fedorova, E.V. Bril, A.A. Tomskiy, A.A. Gamaleya (Moscow, Russia)

    Objective: In this 1-year prospective study, we evaluated the effect of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) on neuropsychiatric complications of…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley